drug policy 1982.ppt

Post on 10-Mar-2016

182 views

Category:

Documents


10 download

TRANSCRIPT

  • Drug (Control) Ordinance 1982

    (National Drug Policy 1982)

  • Bangladesh Drug Market before National Drug Policy 1982

    Science Vs Profit?

    Prepalin Inj. (Glaxo) Digiplex Syp. (Fisons)Decatone Cap. (Fisons)Genasprin Tab. (Fisons)Quixalin Tab. (Squibb)Enterovioform (Ciba)Pentids 200 Tab. (Squibb)Novalgin (Hoechst)Phensidyl Syp. (BPI)Codopyrin Tab. (Glaxo)Clinmycin Syp. (Glaxo) Imperacin Syp. (ICI)Vibramycin Syp. (Pfizer)Terramycin Syp.(Pfizer)

  • Bangladesh Drug Market before National Drug Policy 1982 ..........

    Medicines or Wine ?Mritosanjiboni Sura/Salsa (Ayurvedic Cos.)Verdiviton Elixir (Squibb)Polytamin Syp (Hoechst)Dural Oral Tonic (Pfizer)Nurona Syp. (KDH)Bayers Tonic (Bayer)Fulfords Gripe Water (Fisons)Woodwards Gripe Water (Woodward)

  • Objectives of the National Drug Policy 1982

    To ensure that the common people get the essential and necessary drugs that are of good quality and are useful, effective and safe.To take steps to ensure that the price of the imported as well as the locally manufactured drugs is brought within the reach of the common people.To stop in a gradual way import and manufacture of such costly drugs as are neither essential nor required for treatment and for which appropriate substitutes are available.To provide on a priority basis, required facilities to local drugs manufacturing industries so that self sufficiency is attain in the manufacture of essential drugs.To prohibit the import, manufacture and sale of drugs which have been or will be adjudged useless or injurious by the experts. Any such drug will be immediately banned and steps will be taken to destroy its stock.

  • Objectives of the National Drug Policy 1982 ...........

    6. To exercise government control over advertisement so that common people are not hood-winked by commercial advertisement on health matters and on useless, unnecessary and injurious drugs.7. To exercise control on the import of drugs and raw materials so that these are made available at reasonable price.8. To contract the local companies with the responsibility of manufacturing those drugs which they can produce in adequate quantity and to entrust the foreign companies to gradually manufacture high quality drugs, consistent with their ability and skill.9. To entrust all local/foreign companies with the responsibility of ensuring that all the essential drugs are manufactured in the country.

  • Objectives of the National Drug Policy 1982 ...........

    10. To ban the manufacture, sale and distribution of adulterated and sub-standard drugs and award exemplary punishment to persons guilty of such action. This measure will also be applicable in the case of Ayurvedic, Unani and Homeopathic medicines.11. To constitute necessary number of Drug Courts to try guilty persons and to punish them expeditiously. Such Courts shall have at least the powers of a Sessions Court.12. To strengthen the system of procurement, storage and distribution of drugs and medicines so that these are accessible to people in all areas of the country and also to ensure that there is no wastage of drugs in any hospital.13. To take gradual steps to manufacture, distribute and sell drugs by their generic names.

  • 1972-8270% 5% 3%20105%

    YearImportDrug Import

  • Market Share in 1982 :Total No. of Drug Manufacturers : 166(in Tk.)8 Multinationals: 75%25 Middle-Sized Nationals: 15%133 Small Nationals: 10%

  • Multinationals' Market Share1982-75% - 9%2010 - 7%

  • Pharma Raw Materials Produced in BangladeshAluminium HydroxideCompressed GelAluminium HydroxideDried GelAmoxicillinAmpicillinBlood Transfusion BagCapsule Shell Cefalexin MonohydrateCloxacillinDiclofenac SodiumDiclofenac Diethyl AmineRanitidineOmeprazoleOseltamivirFerrous GluconateFerrous SulphateFlucloxacillinInjection SyringeMagnesium Hydroxide PasteMagnesium Hydroxide PowderParacetamolSulphamethoxazoleTrimethoprimLamivudineZidovudineNelfinavirStavudinePeclitexol

  • Drug Export from Bangladesh 2000 - 2001 : Taka 172 Crore2001 - 2002 : Taka 225 Crore2009 2010: Taka 893 Crore

  • Bangladeshi Drugs are Now Exported to 87 Countries including ......... !!!

    ArgentinaAustriaBelgiumBrazilBulgariaDenmarkFinlandFranceHungaryIndonesiaJordanKuwaitMalaysiaNetherlandsOmanPhilippinesPolandQatarRumaniaSaudi ArabiaSingapore SpainTaiwanUnited Arab EmiratesVenezuelaUSA

  • Comparison of Drug Retail Prices19822001Amoxicillin Capsule(100 x 250 mg)(Amoxyl, Fisons-Beecham)Ampicillin Capsule(100 x 250 mg)(Penbritin, Fisons-Beecham)Doxycycline Capsule(10 x 100 mg)(Vibramycin, Pfizer) US $ 1 = Taka 20.07 (in 1982), Taka 57.36 (in 2001)Tk. 718 Tk. 350Tk. 166 Tk. 250Tk. 39.50 Tk. 20

  • Success Areas of Drug Policy 1982 1. Restriction on Unnecessary and Harmful Drugs.

    2. Disciplined Manufacturing of Drug following GMP by Making Pharmacists Legally Responsible & Accountable. Bangladeshi Drug Becomes Internationally Standard.

    3. Control of Drug Market and More Rational Use. Priority Not on Foreign Patented Drugs, but on Locally Manufactured Ones.

  • 4. Patronizing Local Drug Industries to Lessen Foreign Dependence.Ban on Import of Drugs, Raw Materials and Packaging Materials which are Locally Manufactured.

    5. Keeping Drug Price Stable. Import of Raw and Packaging Materials on Competitive Basis rather than from Designated Sources.

    6. Improvement of Ayurvedic, Unani and Homeopathic Medicines. Modernizing Their Manufacturing and QC Procedures.Success Areas of Drug Policy 1982 .....

  • Key Factors to Maintain This Growth 1. Market Protection by Import Prohibition of Locally Manufactured Drugs, Raw and Packaging Materials.2. Pharmacists to Make for Responsible and Accountable for Production and QC of Drugs according to Clause 13(1) of Drug (Control) Ordinance, 1982.3. To Provide More Cash and Non-Cash Incentives, Easy Income Tax Rebate and Duty Pay-Back to Drug Exporters.

  • Key Factors to Maintain This Growth .............. 4. To Establish a Modern and Central QC and R&D Laboratory in the Private Sector with Government Assistance & Supervision.Local Drug Industries will Share Its Installation and Management.This will Boost Further the Quality and Export Potential.5. To Develop A Drug Bio-equivalence Study Infra-Structure by the Government. Pharmacy Departments, Medical Colleges, BIRDEM and BSMMU to Extend Technical Support.

  • Thank you

    *